Search title Research
Clinical Trials
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Nonalcoholic Steatohepatitis (NASH) and Fibrosis
STATUS: Active, Recruiting
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (Regenerate)
STATUS: Active, Recruiting
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
STATUS: Active, Recruiting
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
STATUS: Active, Recruiting
Publications
Research Studies
Featured Investigator
Sukyung Chung
Ph.D.
Assistant Scientist
Sukyung Chung, Ph.D., is Assistant Scientist at the Palo Alto Medical Foundation's Research Institute (PAMFRI).